Clinical Trials Logo

Clinical Trial Summary

Patients who have undergone the Fontan procedure (a congenital heart surgery) may develop complications many years after their operation. Studies have shown that some of these patients develop an ongoing inflammatory state, which may be the cause of these late complications. Aspirin is a common over the counter anti-inflammatory medication used for many other chronic diseases. This study may help determine if aspirin therapy can limit the inflammation seen in Fontan patients and prevent these late complications.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02966002
Study type Interventional
Source University of Michigan
Contact
Status Terminated
Phase Phase 4
Start date April 2016
Completion date May 25, 2017

See also
  Status Clinical Trial Phase
Completed NCT05063903 - Exercise Capacity in Patients With Fontan Procedure
Terminated NCT01107990 - Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Not yet recruiting NCT06193863 - An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
Completed NCT03726229 - Cholate Clearance in Fontans
Completed NCT00974025 - Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients N/A
Completed NCT02237274 - Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study N/A
Completed NCT05011565 - Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Recruiting NCT05684562 - Pulmonary Determinants of Cardiorespiratory Fitness in Fontan Patients
Completed NCT03503032 - Clinical Outcomes in Fenestrated Extra-Cardiac Fontan in Low Preoperative Risk Profiles